lobbying_activities: 670649

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
670649	d19044e0-3fdf-4a9f-bef6-39ec3fa46b66	Q3	APOTEX CORP.	310973	APOTEX CORP.	2008	third_quarter	PHA	S. 316, the Preserve Access to Affordable Pharmaceuticals Act HR 1902, the Protecting Consumer Access to Generic Drugs Act HR 1038, the Access to Life Savings Medicine Act HR 5629, the Pathway for Biosimilars Act S. 1695, the Biologics Price Competition and Innovation Act HR 5829, the Safeguarding America's Pharmaceuticals Act HR 3610, the Food and Drug Import Safety Act, Section 4 User Fees Regarding Drug Safety PL 110-85, the Foord and Drug Amendments Act of 2007, Section 914, Citizen Petition and petition for stay of agency action PL 110-85, the Food and Drug Amendments Act of 2007. Title VIII, Clinical Trial Databases HR 6432, Animal Drug User Fee Amendments of 2008, Section 301, Consideration of Certain Petitions Combating anti-generic substitution legislation in the states Abbreviated New Drug Application No. 76-396 for calcitonin salmon nasal spray	HOUSE OF REPRESENTATIVES,SENATE		120000	0	0	2008-10-16T15:11:14-04:00